Copyright
©The Author(s) 2015.
World J Pharmacol. Mar 9, 2015; 4(1): 75-95
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.75
Published online Mar 9, 2015. doi: 10.5497/wjp.v4.i1.75
Table 3 Breakpoint and screening cut-off for carbapenemase-producing Enterobacteriaceae
MIC (mg/L) | Disk-diffusion zone diameter (mm) using 10μg disks | |||||||
S breakpoint | Screening cut-off | S breakpoint | Screening cut-off | |||||
EUCAST | CLSI | EUCAST | CLSI | EUCAST | CLSI | EUCAST | CLSI | |
Meropenem | ≤ 2 | ≤ 1 | > 0.12 | 2-4 | ≥ 22 | ≥ 23 | < 25 | 16-21 |
Imipenem | ≤ 2 | ≤ 1 | > 1 | 2-4 | ≥ 22 | ≥ 23 | < 23 | - |
Ertapenem | ≤ 0.5 | ≤ 0.5 | > 0.12 | 2-4 | ≥ 25 | ≥ 22 | < 25 | 19-21 |
- Citation: Sahuquillo-Arce JM, Hernández-Cabezas A, Yarad-Auad F, Ibáñez-Martínez E, Falomir-Salcedo P, Ruiz-Gaitán A. Carbapenemases: A worldwide threat to antimicrobial therapy. World J Pharmacol 2015; 4(1): 75-95
- URL: https://www.wjgnet.com/2220-3192/full/v4/i1/75.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i1.75